Новые возможности патогенетической терапии при хроническом простатите

Проведен аналитический обзор 172 источников отечественной и зарубежной литературы по возможностям патогенетической терапии пациентов с хроническим простатитом/синдромом хронической тазовой боли с помощью многофункциональных нутрицевтиков и микроэлементов, скомпонованных в биологически активном комплексе Кверцепрост: кверцетин, ликопин, нарингин, селен и цинк. Показано многокомпонентное действие Кверцепроста – антимутагенное, противовоспалительное, кардиозащитное и нейропротекторное. Кверцепрост подавляет окислительный стресс, сохраняет оксид азота и целостность эндотелия, модулирует нейрогормональные системы и активирует провыживательные сигналы в клетках, одновременно ингибируя апоптоз, аутофагию и ферроптоз.

1. Nickel C.J. Prostatitis syndromes: an update for urologic practice. Can J Urol 2000;7(5):1091–8.

2. Liu J., Liu L., Zhang G., Peng X. Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis. Int J Biol Macromol 2021;189:346–55. DOI: 10.1016/j.ijbiomac.2021.08.139

3. Lam J.C., Stokes W. Acute and chronic prostatitis. Am Fam Physician 2024;110(1):45–51.

4. Naber K.G., Weidner W. Chronic prostatitis‑an infectious disease? J Antimicrob Chemother 2000;46(2):157–61. DOI: 10.1093/jac/46.2.157.6

5. Khan F.U., Ihsan A.U., Khan H.U. et al. Comprehensive overview of prostatitis. Biomed Pharmacother 2017;94:1064–76. DOI: 10.1016/j.biopha.2017.08.016

6. Krieger J.N., Nyberg L. Jr, Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA 1999;282(3):236–7. DOI: 10.1001/jama.282.3.236

7. Millardet A. Note sur une substance colorante nouvelle decouverte dans la tomate. Bull Soc Sci Nancy 1875;2:21–5.

8. Vogele A.C. Effect of environmental factors upon the color of the tomato and the watermelon. Plant Physiol 1937;12:929–55. DOI: 10.1104/pp.12.4.929

9. Schunck C.A. The xanthophyll group of yellow coloring matters. Proc R Soc 1903;72:165–76.

10. Abridged List Ordered by Nutrient Content in Household Measure. Available at: https://www.nal.usda.gov/sites/default/files/page‑files/Lycopene.pdf (accessed on 11 April 2025).

11. Napolitano M., De Pascale C., Wheeler‑Jones C. et al. Effects of lycopene on the induction of foam cell formation by modified LDL. Am J Physiol Endocrinol Metab 2007;293(6):E1820–7. DOI: 10.1152/ajpendo.00315.2007

12. Ono M., Takeshima M., Nakano S. Mechanism of the anticancer effect of lycopene (tetraterpenoids). Enzymes 2015;37:139–66. DOI: 10.1016/bs.enz.2015.06.002

13. Nieto G., Martínez‑Zamora L., Peñalver R. et al. Applications of plant bioactive compounds as replacers of synthetic additives in the food industry. Foods 2023;13(1):47. DOI: 10.3390/foods13010047

14. Imran M., Ghorat F., Ul‑Haq I. et al. Lycopene as a natural antioxidant used to prevent human health disorders. Antioxidants (Basel) 2020;9(8):706. DOI: 10.3390/antiox9080706

15. Song B., Liu K., Gao Y. et al. Lycopene and risk of cardiovascular diseases: a meta‑analysis of observational studies. Mol Nutr Food Res 2017;61:1601009. DOI: 10.1002/mnfr.201601009

16. Cheng H.M., Koutsidis G., Lodge J.K. et al. Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta‑analysis of epidemiological evidence. Crit Rev Food Sci Nutr 2019;59:141–58. DOI: 10.1080/10408398.2017.1362630

17. Rattanavipanon W., Nithiphongwarakul C., Sirisuwansith P. et al. Effect of tomato, lycopene and related products on blood pressure: A systematic review and network meta‑analysis. Phytomedicine 2021;88:153512. DOI: 10.1016/j.phymed.2021.153512

18. Simon L., Zini A., Dyachenko A. et al. A systematic review and meta‑analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome. Asian J Androl 2017;19:80–90. DOI: 10.4103/1008‑682x.182822

19. Viña I., Viña J.R. Association of lycopene and male reproductive health: systematic review and meta‑analysis. Int J Mol Sci 2025;26(15):7224. DOI: 10.3390/ijms26157224

20. De Lamirande E., O’Flaherty C. Sperm activation: role of reactive oxygen species and kinases. Biochim Biophys Acta 2008;1784:106–15. DOI: 10.1016/j.bbapap.2007.08.024

21. Vakili S., Samare‑Najaf M., Karimi A. et al. Lycopene in male infertility. Naunyn Schmiedebergs Arch Pharmacol 2025;398(5):4817–35. DOI: 10.1007/s00210‑024‑03520‑x

22. Shafe M.O., Gumede N.M., Nyakudya T.T., Chivandi E. Lycopene: a potent antioxidant with multiple health benefits. J Nutr Metab 2024;2024:6252426. DOI: 10.1155/2024/6252426

23. Shen Y., Zhang J., Li L. et al. Lycopene ameliorates D‑galactose‑induced hepatic senescence in CD‑1 female mice through fibroblast growth factor 21/mitochondrial dynamics mediation. Wei Sheng Yan Jiu 2025;54:265–72. DOI: 10.19813/j.cnki.weishengyanjiu.2025.02.014

24. Wang X.Q., Chang Y.H., Wang X.C. et al. SIRT1 regulates fumonisin B1‑induced LMH cell PANoptosis and antagonism of lycopene. J Agric Food Chem 2025;73:4923–35. DOI: 10.1021/acs.jafc.4c1165

25. Wan X.L., Li N., Chen Y.J. et al. Protective effects of lycopene on mitochondrial oxidative injury and dysfunction in the liver of aflatoxin B1‑exposed broilers. Poult Sci 2021;100:101441. DOI: 10.1016/j.psj.2021.101441

26. Moslemi E., Nouri M., Askari G. Effect of lycopene supplementation on infertility in men: A systematic review on clinical trial studies. Qom Univ Med Sci J 2019;12:28–41. DOI: 10.29252/qums.12.12.28

27. Nouri M., Amani R., Nasr‑Esfahani M., Tarrahi M.J. The effects of lycopene supplement on the spermatogram and seminal oxidative stress in infertile men: a randomized, double‑blind, placebo‑controlled clinical trial. Phytother Res 2019;33:3203–11. DOI: 10.1002/ptr.6493

28. Sadeghi N., Boissonneault G., Tavalaee M., Nasr‑Esfahani M.H. Oxidative versus reductive stress: a delicate balance for sperm integrity. Syst Biol Reprod Med 2023;69:20–31. DOI: 10.1080/19396368.2022.2119181

29. Williams E.A., Parker M., Robinson A. et al. A randomized placebo‑controlled trial to investigate the effect of lactolycopene on semen quality in healthy males. Eur J Nutr 2020;59:825–33. DOI: 10.1007/s00394‑019‑02091‑5

30. Yamamoto Y., Aizawa K., Mieno M. et al. The effects of tomato juice on male infertility. Asia Pac J Clin Nutr 2017;26:65–71. DOI: 10.6133/apjcn.102015.17

31. Gupta N.P., Kumar R. Lycopene therapy in idiopathic male infertility – a preliminary report. Int Urol Nephrol 2002;34:369–72. DOI: 10.1023/A:1024483520560

32. Wu S., Guo X., Shang J. et al. Effects of lycopene attenuating injuries in ischemia and reperfusion. Oxidative Med Cell Longev 2022;2022:9309327. DOI: 10.1155/2022/9309327

33. Saini R.K., Rengasamy K.R.R., Mahomoodally F.M., Keum Y.S. Protective effects of lycopene in cancer, cardiovascular, and neurodegenerative diseases: an update on epidemiological and mechanistic perspectives. Pharmacol Res 2020;155:104730. DOI: 10.1016/j.phrs.2020.104730

34. Głąbska D., Guzek D., Jílková A. et al. Influence of lycopene intake on mental health: a systematic review of randomized controlled trials (RCTs). Nutrients 2025;17(11):1793. DOI: 10.3390/nu17111793

35. Shayestehyekta M., Faramarzi A., Rashidi Z., Moradi M. Lycopene as a protective antioxidant in sperm preservation. Anim Reprod Sci 2025;285:108075. DOI: 10.1016/j.anireprosci.2025.108075

36. Maaz M., Sultan M.T., Khalid M.U. et al. A comprehensive review on the molecular mechanism of lycopene in cancer therapy. Food Sci Nutr 2025;13(7):e70608. DOI: 10.1002/fsn3.70608

37. Joshi B., Kar S.K., Yadav P.K. et al. Therapeutic and medicinal uses of lycopene: a systematic review. Int J Res Med Sci 2020;8:1195–201. DOI: 10.18203/2320‑6012.ijrms20200804

38. Paul R., Mazumder M.K., Nath J. et al. Lycopene – a pleiotropic neuroprotective nutraceutical: deciphering its therapeutic potentials in broad spectrum neurological disorders. Neurochem Int 2020;140:104823. DOI: 10.1016/j.neuint.2020.104823

39. Niu K., Guo H., Kakizaki M. et al. A tomato‑rich diet is related to depressive symptoms among an elderly population aged 70 years and over: a population‑based, cross‑sectional analysis. J Affect Disord 2013;144:165–70. DOI: 10.1016/j.jad.2012.04.040

40. Li X., Lan Y. Association between higher dietary lycopene intake and reduced depression risk among American adults: evidence from NHANES 2007–2016. Front Nutr 2025;12:1538396. DOI: 10.3389/fnut.2025.1538396

41. Pereira G.A., da Silva A., Hermsdorff H.H.M. et al. Association of dietary total antioxidant capacity with depression, anxiety, and sleep disorders: a systematic review of observational studies. J Clin Transl Res 2021;7:631–40.

42. Осадчий А.В., Кульчавеня Е.В., Рейхруд Т.А. и др. Социально‑демографическая характеристика больных туберкулезом легких и внелегочных локализаций. Туберкулез и болезни легких 2015;2:46–9. DOI: 10.21292/2075‑1230‑2015‑0‑2‑46‑49

43. Cheon S.Y. Impaired cholesterol metabolism, neurons, and neuropsychiatric disorders. Exp Neurobiol 2023;32:57–67. DOI: 10.5607/en23010

44. Penckofer S., Quinn L., Byrn M. et al. Does glycemic variability impact mood and quality of life? Diabetes Technol Ther 2012;14:303–10. DOI: 10.1089/dia.2011.0191

45. Jin J. Lycopene intake and the risk of erectile dysfunction in US adults: the National Health and Nutrition Examination Survey 2001–2004. Andrology 2025;13(7):1987–8. DOI: 10.1111/andr.13813

46. Inoue T., Yoshida K., Sasaki E. et al. Effect of lycopene intake on the fasting blood glucose level: a systematic review with meta‑analysis. Nutrients 2022;15:122. DOI: 10.3390/nu15010122

47. Yin S., Xu X., Li Y. et al. Lycopene as a potential anticancer agent: current evidence on synergism, drug delivery systems and epidemiology (Review). Oncol Lett 2025;30(4):462. DOI: 10.3892/ol.2025.15208

48. Bray F., Laversanne M., Sung H. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229–63. DOI: 10.3322/caac.21834

49. Chen J., Zhang L.G., Du H.X. et al. Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1‑dependent inhibition of the NLRP3 inflammasome in an EAP mouse model. Prostate 2021;81(15):1179–90. DOI: 10.1002/pros.24214

50. Balali A., Fathzadeh K., Askari G., Sadeghi O. Dietary intake of tomato and lycopene, blood levels of lycopene, and risk of total and specific cancers in adults: a systematic review and dose‑response meta‑analysis of prospective cohort studies. Front Nutr 2025;12:1516048. DOI: 10.3389/fnut.2025.1516048

51. Viña I., Robles A., Viña J.R. Association between lycopene and metabolic disease risk and mortality: systematic review and meta‑analysis. Life (Basel) 2025;15(6):944. DOI: 10.3390/life15060944

52. Palozza P., Parrone N., Simone R.E., Catalano A. Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies. Arch Biochem Biophys 2010;504:26–33. DOI: 10.1016/j.abb.2010.06.031

53. Chen X., Yang G., Liu M. et al. Lycopene enhances the sensitivity of castration‑resistant prostate cancer to enzalutamide through the AKT/EZH2/androgen receptor signaling pathway. Biochem Biophys Res Commun 2022;613:53–60. DOI: 10.1016/j.bbrc.2022.04.126

54. Chen J., O’Donoghue A., Deng Y.F. et al. The effect of lycopene on the PI3K/Akt signalling pathway in prostate cancer. Anticancer Agents Med Chem 2014;14(6):800–5. DOI: 10.2174/1871520614666140521121317

55. Devlin C.M., Simms M.S., Maitland N.J. Benign prostatic hyperplasia – what do we know? BJU Int 2021;127(4):389–99. DOI: 10.1111/bju.15229

56. Ozkan G., Günal‑Köroğlu D., Karadag A. et al. A mechanistic updated overview on lycopene as potential anticancer agent. Biomed Pharmacother 2023;161:114428. DOI: 10.1016/j.biopha.2023.114428

57. Mia M.A.R., Dey D., Sakib M.R. et al. The efficacy of natural bioactive compounds against prostate cancer: molecular targets and synergistic activities. Phytother Res 2023;37(12):5724–54. DOI: 10.1002/ptr.8017

58. Matsushita M., Fujita K., Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci 2020;21(4):1447. DOI: 10.3390/ijms21041447

59. Lu Y., Edwards A., Chen Z. et al. Insufficient lycopene intake is associated with high risk of prostate cancer: a Cross‑sectional study from the national health and nutrition examination survey (2003–2010) Front Public Health 2021;9:792572. DOI: 10.3389/fpubh.2021.792572

60. Wang Y., Cui R., Xiao Y. et al. Effect of carotene and lycopene on the risk of prostate cancer: a systematic review and dose‑response meta‑analysis of observational studies. PLoS One 2015;10:e0137427. DOI: 10.1371/journal.pone.0137427

61. Zu K., Mucci L., Rosner B.A. et al. Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate‑specific antigen era. J Natl Cancer Inst 2014;106:djt430. DOI: 10.1093/jnci/djt430

62. López‑Solís R., Castro‑Barquero S., Donat‑Vargas C. et al. Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study. BMC Med 2025;23(1):627. DOI: 10.1186/s12916‑025‑04440‑0

63. Ansari M.S., Gupta N.P. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol Oncol 2004;22:415–20. DOI: 10.1016/S1078‑1439(04)00122‑X

64. Zhang X., Yang Y., Wang Q. Lycopene can reduce prostate‑specific antigen velocity in a phase II clinical study in Chinese population. Chin Med J (Engl) 2014;127:2143–6. DOI: 10.3760/cma.j.issn.0366‑6999.20132829

65. Bhuvaneswari V., Velmurugan B., Nagini S. Dose‑response effect of tomato paste on 7,12‑dimethylbenz[a]anthracene‑induced hamster buccal pouch carcinogenesis. J Exp Clin Cancer Res 2004;23(2):241–9.

66. Zhang B., Gu Y. Low expression of ERK signaling pathway affecting proliferation, cell cycle arrest and apoptosis of human gastric HGC‑27 cells line. Mol Biol Rep 2014;41(6):3659–69. DOI: 10.1007/s11033‑014‑3230‑6

67. Morgia G., Lo Giudice A., Cimino S. et al. Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: an Italian multicenter case‑control prospective study (COMP study). Front Urol 2025;5:1565240. DOI: 10.3389/fruro.2025.1565240

68. Schwarz S., Obermüller‑Jevic U.C., Hellmis E. et al. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 2008;138(1):49–53. DOI: 10.1093/jn/138.1.49

69. Yoshida K., Nakazawa Y., Takahashi S., Suzuki S. Improvement of vascular endothelial function by intake of lycopene‑rich tomato juice in healthy adults: a randomized, placebo‑controlled, double‑blind, parallel‑group comparative study. Food Funct 2025;16(19):7812–22. DOI: 10.1039/d5fo01397f

70. Gao Y., Liu C., Lu X. et al. Lycopene intake and the risk of erectile dysfunction in US adults: NHANES 2001–2004. Andrology 2024;12(1):45–55. DOI: 10.1111/andr.13439

71. Nakadate K., Ito N., Kawakami K., Yamazaki N. Anti‑inflammatory actions of plant‑derived compounds and prevention of chronic diseases: from molecular mechanisms to applications. Int J Mol Sci 2025;26(11):5206. DOI: 10.3390/ijms26115206

72. Shilpa V.S., Shams R., Dash K.K. et al. Phytochemical properties, extraction, and pharmacological benefits of naringin: a review. Molecules 2023;28:5623. DOI: 10.3390/molecules28155623

73. Alam F., Mohammadin K., Shafique Z. et al. Citrus flavonoids as potential therapeutic agents: a review. Phytother Res 2022;36:1417–41. DOI: 10.1002/ptr.7261

74. Adams J.A., Uryash A., Mijares A. et al. Endothelial and cardiovascular effects of naringin: a systematic review. Nutrients 2025;17(16):2658. DOI: 10.3390/nu17162658

75. Khamseekaew J., Iampanichakul M., Potue P. et al. The alleviative effect of naringin against cardiovascular dysfunction and remodeling in hypertensive rats by suppressing the angiotensin II pathway. Food Sci Nutr 2025;13:e70484. DOI: 10.1002/fsn3.70484

76. Lu Y., Li D.H., Xu J.M., Zhou S. Role of naringin in the treatment of atherosclerosis. Front Pharmacol 2024;15:1451445. DOI: 10.3389/fphar.2024.1451445

77. Salehi B., Fokou P.V.T., Sharifi‑Rad M. et al. The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals 2019;12:11. DOI: 10.3390/ph12010011

78. Viswanatha G.L., Shylaja H., Keni R. et al. A systematic review and meta‑analysis on the cardio‑protective activity of naringin based on pre‑clinical evidences. Phytother Res 2022;36:1064–92. DOI: 10.1002/ptr.7368

79. Yaseen H.S., Zubair H.M., Jamal A. et al. Naringin: cardioprotective properties and safety profile in diabetes treatment. Fitoterapia 2024;176:106011. DOI: 10.1016/j.fitote.2024.106011

80. Zaragoza C., Villaescusa L., Monserrat J. et al. Potential therapeutic anti‑inflammatory and immunomodulatory effects of dihydroflavones, flavones, and flavonols. Molecules 2020;25:1017. DOI: 10.3390/molecules25041017

81. Alam M., Ahsan F., Mahmood T. et al. Meticulous parade on naringin respecting its pharmacological activities and novel formulations. Avicenna J Phytomed 2022;12:457–74. DOI: 10.22038/AJP.2022.20001

82. Ravetti S., Garro A.G., Gaitán A. et al. Naringin. Encyclopedia. Available at: https://encyclopedia.pub/entry/42479 (accessed on 26 February 2024).

83. Adetunji J.A., Fasae K.D., Awe A.I. et al. The protective roles of citrus flavonoids, naringenin, and naringin on endothelial cell dysfunction in diseases. Heliyon 2023;9:e17166. DOI: 10.1016/j.heliyon.2023.e17166

84. Ghanbari‑Movahed M., Jackson G., Farzaei M.H., Bishayee A. A systematic review of the preventive and therapeutic effects of naringin against human malignancies. Front Pharmacol 2021;12:639840. DOI: 10.3389/fphar.2021.639840

85. Miles E.A., Calder P.C. Effects of citrus fruit juices and their bioactive components on inflammation and immunity: a narrative review. Front Immunol 2021;12:712608. DOI: 10.3389/fimmu.2021.712608

86. Bharti S., Rani N., Krishnamurthy B., Arya D.S. Preclinical evidence for the pharmacological actions of naringin: a review. Planta Med 2014;80(6):437–51. DOI: 10.1055/s‑0034‑1368351

87. Demonty I., Lin Y., Zebregs Y.E. et al. The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J Nutr 2010;140:1615–20. DOI: 10.3945/jn.110.124735

88. Wang C., Yang T., Xiao J. et al. NLRP3 inflammasome activation triggers gasdermin D‑independent inflammation. Sci Immunol 2021;6(64):eabj3859. DOI: 10.1126/sciimmunol.abj3859

89. Wang L., Cai J., Zhao X et al. Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone‑mediated autophagy. Mol Cell 2023;83(2):281–97.e10. DOI: 10.1016/j.molcel.2022.12.002

90. Chen T., Zhang X., Zhu G. et al. Quercetin inhibits TNF‑alpha induced HUVECs apoptosis and inflammation via downregulating NF‑kB and AP‑1 signaling pathway in vitro. Medicine 2020;99:e22241. DOI: 10.1097/MD.0000000000022241

91. Zhou W., Zhang X.R., Qin X.C. et al. Naringin mitigates experimental autoimmune prostatitis by modulating oxidative stress and the NLRP3 inflammasome via the PPAR‑γ/NF‑κB pathway. Sci Rep 2025;15(1):20843. DOI: 10.1038/s41598‑025‑04916‑2

92. Кузьменко А.В., Гяургиев Т.А., Кузьменко В.В., Кузьменко Г.А. Применение антиоксидантов в комплексной терапии хронического простатита. Урология 2024;1:162–7. DOI: 10.18565/urology.2024.1.162‑167

93. Братчиков О.И., Дубонос П.А., Тюзиков И.А., Шумакова Е.А. Механизмы окислительного стресса в патогенезе хронического бактериального простатита (обзор литературы). Андрология и генитальная хирургия 2022;23(3):19–28. DOI: 10.17650/2070‑9781‑2022‑23‑3‑19‑28

94. Чиряпкин А.С., Золотых Д.С., Поздняков Д.И. Обзор биологической активности флавоноидов: кверцетина и кемпферола. Juvenis scientia 2023;9(2):5–20. DOI: 10.32415/jscientia_2023_9_2_5‑20

95. Gercek E., Zengin H., Erdem Erisir F., Yilmaz O. Biochemical changes and antioxidant capacity of naringin and naringenin against malathion toxicity in Saccharomyces cerevisiae. Comp Biochem Physiol C Toxicol Pharmacol 2021;241:108969. DOI: 10.1016/j.cbpc.2020.108969

96. Hsueh T.P., Sheen J.M., Pang J.H. et al. The anti‑atherosclerotic effect of naringin is associated with reduced expressions of cell adhesion molecules and chemokines through NF‑kappaB pathway. Molecules 2016;21:195. DOI: 10.3390/molecules21020195

97. Lee E.J., Kim D.I., Kim W.J., Moon S.K. Naringin inhibits matrix metalloproteinase‑9 expression and AKT phosphorylation in tumor necrosis factor‑alpha‑induced vascular smooth muscle cells. Mol Nutr Food Res 2009;53:1582–91. DOI: 10.1002/mnfr.200800210

98. Zhao H., Zhao J. Study on the role of naringin in attenuating Trimethylamine‑N‑Oxide‑Induced human umbilical vein endothelial cell inflammation, oxidative stress, and endothelial dysfunction. Chin J Physiol 2022;65:217–25. DOI: 10.4103/0304‑4920.359796

99. Rizza S., Muniyappa R., Iantorno M. et al. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab 2011;96:E782–92. DOI: 10.1210/jc.2010‑2879

100. Pengnet S., Prommaouan S., Sumarithum P., Malakul W. Naringin Reverses high‑cholesterol diet‑induced vascular dysfunction and oxidative stress in rats via regulating LOX‑1 and NADPH oxidase subunit expression. BioMed Res Int 2019;2019:3708497. DOI: 10.1155/2019/3708497

101. Xu S., Wu B., Zhong B. et al. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor‑erythroid factor 2‑related factor 2 (Nrf2)/System xc‑/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 2021;12:10924–34. DOI: 10.1080/21655979.2021.1995994

102. Li F., Zhan Z., Qian J. et al. Naringin attenuates rat myocardial ischemia/reperfusion injury via PI3K/Akt pathway‑mediated inhibition of apoptosis, oxidative stress and autophagy. Exp Ther Med 2021;22:811. DOI: 10.3892/etm.2021.10243

103. Alhalmi A., Amin S., Ralli T. et al. Therapeutic role of naringin in cancer: molecular pathways, synergy with other agents, and nanocarrier innovations. Naunyn Schmiedebergs Arch Pharmacol 2025;398(4):3595–615. DOI: 10.1007/s00210‑024‑03672‑w

104. Deepika, Maurya P.K. Health benefits of quercetin in age‑related diseases. Molecules 2022;27(8):2498. DOI: 10.3390/molecules27082498

105. Jafarinia M., Sadat Hosseini M., Kasiri N. et al. Quercetin with the potential effect on allergic diseases. Allergy Asthma Clin Immunol 2020;16:36. DOI: 10.1186/s13223‑020‑00434‑0

106. Andres S., Pevny S., Ziegenhagen R. et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res 2018;62:170047. DOI: 10.1002/mnfr.201700447

107. Babaei F., Mirzababaei M., Nassiri‑Asl M. Quercetin in food: possible mechanisms of its effect on memory. J Food Sci 2018;83:2280–7. DOI: 10.1111/1750‑3841.14317

108. Nguyen T.L.A., Bhattacharya D. Antimicrobial activity of quercetin: an approach to its mechanistic principle. Molecules 2022;27(8):2494. DOI: 10.3390/molecules27082494

109. Sato S., Mukai Y. Modulation of chronic inflammation by quercetin: the beneficial effects on obesity. J Inflamm Res 2020;13:421–31. DOI: 10.2147/JIR.S228361

110. Li Y., Yao J., Han C. et al. Quercetin, inflammation and immunity. Nutrients 2016;8(3):167. DOI: 10.3390/nu8030167

111. Yang D., Wang T., Long M., Li P. Quercetin: its main pharmacological activity and potential application in clinical medicine. Oxid Med Cell Longev 2020;2020:8825387. DOI: 10.1155/2020/8825387

112. Batiha G.E., Beshbishy A.M., Ikram M. et al. The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods 2020;9:374. DOI: 10.3390/foods9030374

113. Mlcek J., Jurikova T., Skrovankova S., Sochor J. Quercetin and its anti‑allergic immune response. Molecules 2016;21(5):623. DOI: 10.3390/molecules21050623

114. Roman G.C., Jackson R.E., Gadhia R. et al. Mediterranean diet: the role of long‑chain omega‑3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age‑related cognitive decline, and Alzheimer disease. Rev Neurol 2019;175:724–41. DOI: 10.1016/j.neurol.2019.08.005

115. Bostancieri N., Elbe H., Esrefoglu M., Vardi N. Cardioprotective potential of melatonin, quercetin and resveratrol in an experimental model of diabetes. Biotech Histochem 2022;97:152–7. DOI: 10.1080/10520295.2021.1918766

116. Lai L.L., Lu H.Q., Li W.N. et al. Protective effects of quercetin and crocin in the kidneys and liver of obese Sprague‑Dawley rats with Type 2 diabetes: effects of quercetin and crocin on T2DM rats. Hum Exp Toxicol 2021;40:661–72. DOI: 10.1177/0960327120954521

117. Shafabakhsh R., Asemi Z. Quercetin: a natural compound for ovarian cancer treatment. J Ovarian Res 2019;12:55. DOI: 10.1186/s13048‑019‑0530‑4

118. Massi A., Bortolini O., Ragno D. et al. Research progress in the modification of quercetin leading to anticancer agents. Molecules 2017;22:1270. DOI: 10.3390/molecules22081270

119. Tang S.M., Deng X.T., Zhou J. et al. Pharmacological basis and new insights of quercetin action in respect to its anti‑cancer effects. Biomed Pharm 2020;121:109604. DOI: 10.1016/j.biopha.2019.109604

120. Ward A.B., Mir H., Kapur N. et al. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti‑apoptotic pathways. World J Surg Oncol 2018;16:108. DOI: 10.1186/s12957‑018‑1400‑z

121. Brisdelli F., Di Francesco L., Giorgi A. et al. Proteomic analysis of quercetin‑treated K562 cells. Int J Mol Sci 2019;21:32. DOI: 10.3390/ijms21010032

122. Chirumbolo S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets 2010;9(4):263–85. DOI: 10.2174/187152810793358741

123. Diniz L.R.L., Souza M.T.S., Duarte A.B.S., Sousa D.P. Mechanistic aspects and therapeutic potential of quercetin against COVID‑19‑associated acute kidney injury. Molecules 2020;25:5772. DOI: 10.3390/molecules25235772

124. Chen P., Zhang W., Wang X. et al. Lycopene and risk of prostate cancer: a systematic review and meta‑analysis. Medicine 2015;94:e1260. DOI: 10.1097/MD.0000000000001260

125. Escribano‑Ferrer E., Queralt Regue J., Garcia‑Sala X. et al. In vivo anti‑inflammatory and antiallergic activity of pure naringenin, naringenin chalcone, and quercetin in mice. J Nat Prod 2019;82:177–82. DOI: 10.1021/acs.jnatprod.8b00366

126. Yamasaki S., Asakura M., Neogi S.B. et al. Inhibition of virulence potential of Vibrio cholerae by natural compounds. Indian J Med Res 2011;133:232–9.

127. Shu Y., Liu Y., Li L. et al. Antibacterial activity of quercetin on oral infectious pathogens. Afr J Microbiol Res 2011;5:5358–61.

128. Cushnie T.P.T., Lamb A.J. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005;26:343–56. DOI: 10.1016/j.ijantimicag.2005.09.002

129. Osonga F.J., Akgul A., Miller R.M. et al. Antimicrobial activity of a new class of phosphorylated and modified flavonoids. ACS Omega 2019;4:12865–71. DOI: 10.1021/acsomega.9b00077

130. Ohemeng K.A., Schwender C.F., Fu K.P., Barrett J.F. DNA gyrase inhibitory and antibacterial activity of some flavones (1). Bioorg Med Chem Lett 1993;3:225–30. DOI: 10.1016/S0960‑894X(01)80881‑7

131. Wang S., Yao J., Zhou B. et al. Bacteriostatic effect of quercetin as an antibiotic alternative in vivo and its antibacterial mechanism in vitro. J Food Prot 2018;81:68–78. DOI: 10.4315/0362‑028X.JFP‑17‑214

132. Plaper A., Golob M., Hafner I. et al. Characterization of quercetin binding site on DNA gyrase. Biochem Biophys Res Commun 2003;306:530–6. DOI: 10.1016/S0006‑291X(03)01006‑4

133. Lee J.H., Park J.H., Cho H.S. et al. Anti‑biofilm activities of quercetin and tannic acid against Staphylococcus aureus. Biofouling 2013;29:491–9. DOI: 10.1080/08927014.2013.788692

134. Qayyum S., Sharma D., Bisht D., Khan A.U. Identification of factors involved in Enterococcus faecalis biofilm under quercetin stress. Microb Pathog 2019;126:205–11. DOI: 10.1016/j.micpath.2018.11.013

135. Ouyang J., Sun F., Feng W. et al. Quercetin is an effective inhibitor of quorum sensing, biofilm formation and virulence factors in Pseudomonas aeruginosa. J Appl Microbiol 2016;120:966–74. DOI: 10.1111/jam.13073

136. Manner S., Fallarero A. Screening of natural product derivatives identifies two structurally related flavonoids as potent quorum sensing inhibitors against gram‑negative bacteria. Int J Mol Sci 2018;19:1346. DOI: 10.3390/ijms19051346

137. He Z., Zhang X., Song Z. et al. Quercetin inhibits virulence properties of Porphyromas gingivalis in periodontal disease. Sci Rep 2020;10:18313. DOI: 10.1038/s41598‑020‑74977‑y

138. Xu J., Hu H., Jiang H. et al. The therapeutic mechanisms of quercetin on inflammatory diseases: an update. Inflammopharmacology 2025;33(6):3015–49. DOI: 10.1007/s10787‑025‑01795‑x

139. Zhang M., Swarts S.G., Yin L. et al. Antioxidant properties of quercetin. Adv Exp Med Biol 2011;701:283–9. DOI: 10.1007/978‑1‑4419‑7756‑4_38

140. Pietta P.G. Flavonoids as antioxidants. J Nat Prod 2000;63:1035–42. DOI: 10.1021/np9904509

141. Qi W., Qi W., Xiong D., Long M. Quercetin: its antioxidant mechanism, antibacterial properties and potential application in prevention and control of toxipathy. Molecules 2022;27(19):6545. DOI: 10.3390/molecules27196545

142. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585:325–37. DOI: 10.1016/j.ejphar.2008.03.008

143. Ullah F., Iqbal N., Ayaz M. et al. DPPH, ABTS free radical scavenging, antibacterial and phytochemical evaluation of crude methanolic extract and subsequent fractions of Chenopodium botrys aerial parts. Pak J Pharm Sci 2017;30:761–6.

144. Granado‑Serrano A.B., Martin M.A., Bravo L. et al. Quercetin modulates Nrf2 and glutathione‑related defenses in HepG2 cells: Involvement of p38. Chem Biol Interact 2012;195:154–64. DOI: 10.1016/j.cbi.2011.12.005

145. Fernandez‑Sanchez A., Madrigal‑Santillan E., Bautista M. et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011;12:3117–32. DOI: 10.3390/ijms12053117

146. Prasad J., Baitharu I., Sharma A.K. et al. Quercetin reverses hypobaric hypoxia‑induced hippocampal neurodegeneration and improves memory function in the rat. High Alt Med Biol 2013;14:383–94. DOI: 10.1089/ham.2013.1014

147. Kawamura K., Qi F., Kobayashi J. Potential relationship between the biological effects of low‑dose irradiation and mitochondrial ROS production. J Radiat Res 2018;59:i91–7. DOI: 10.1093/jrr/rrx091

148. Tvrda E., Tusimova E., Kovacik A. et al. Protective effects of quercetin on selected oxidative biomarkers in bovine spermatozoa subjected to ferrous ascorbate. Reprod Domest Anim 2016;51:524–37. DOI: 10.1111/rda.12714

149. Fischer C., Speth V., Fleig‑Eberenz S., Neuhaus G. Induction of zygotic polyembryos in wheat: Influence of auxin polar transport. Plant Cell 1997;9:1767–80. DOI: 10.2307/3870523

150. Zhou S., Qingman X., Zhang W. et al. Quercetin as a multi‑target natural therapeutic in aging‑related diseases: systemic molecular and cellular mechanisms. Phytother Res 2025;39(10):4821–69. DOI: 10.1002/ptr.70078

151. Chiang M.C., Tsai T.Y., Wang C.J. The potential benefits of quercetin for brain health: a review of anti‑inflammatory and neuroprotective mechanisms. Int J Mol Sci 2023;24(7):6328. DOI: 10.3390/ijms24076328

152. Yang D., Zhang C., Ma J. et al. Selenium homeostasis and male reproduction. Biochem Biophys Res Commun 2025;765:151879. DOI: 10.1016/j.bbrc.2025.151879

153. Mintziori G., Mousiolis A., Duntas L.H., Goulis D.G. Evidence for a manifold role of selenium in infertility. Hormones (Athens) 2020;19(1):55–9. DOI: 10.1007/s42000‑019‑00140‑6

154. Cui Z., Xie R., Lu X. et al. Associations of selenium status with all‑cause and cause‑specific mortality: a systematic review and meta‑analysis of cohort studies. Redox Biol 2025;85:103755. DOI: 10.1016/j.redox.2025.103755

155. Razzaque M.S., Wimalawansa S.J. Minerals and human health: from deficiency to toxicity. Nutrients 2025;17(3):454. DOI: 10.3390/nu17030454

156. Baddam S., Maxfield L., Shukla S., Crane J.S. Zinc deficiency 2025. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025.

157. Maret W. The arcana of zinc. J Nutr 2025;155(3):669–75. DOI: 10.1016/j.tjnut.2025.01.004

158. Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physiol Rev 1993;73(1):79–118. DOI: 10.1152/physrev.1993.73.1.79

159. Hanas J.S., Hazuda D.J., Bogenhagen D.F. et al. Xenopus transcription factor A requires zinc for binding to the 5S RNA gene. J Biol Chem 1983;258(23):14120–5.

160. Klug A., Rhodes D. “Zinc fingers”: a novel protein motif for nucleic acid recognition. Trends Biochem Sci 1987;12:464–9.

161. Andreini C., Banci L., Bertini I., Rosato A. Counting the zinc‑proteins encoded in the human genome. J Proteome Res 2006;5(1):196–201. DOI: 10.1021/pr050361

162. Kocyła A., Tran J.B., Krężel A. Galvanization of protein‑protein interactions in a dynamic zinc interactome. Trends Biochem Sci 2021;46(1):64–79. DOI: 10.1016/j.tibs.2020.08.011

163. Berg J.M., Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science 1996;271(5252):1081–5. DOI: 10.1126/science.271.5252.1081

164. Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr 2013;4(1):82–91. DOI: 10.3945/an.112.003038

165. Schulz M.T., Rink L. Zinc deficiency as possible link between immunosenescence and age‑related diseases. Immun Ageing 2025;22(1):19. DOI: 10.1186/s12979‑025‑00511‑1

166. Frederickson C.J., Koh J.Y., Bush A.I. The neurobiology of zinc in health and disease. Nat Rev Neurosci 2005;6(6):449–62. DOI: 10.1038/nrn1671

167. Maret W. Zinc in cellular regulation: the nature and significance of “zinc signals”. Int J Mol Sci 2017;18(11):2285. DOI: 10.3390/ijms18112285

168. Maret W. Zinc in pancreatic islet biology, insulin sensitivity, and diabetes. Prev Nutr Food Sci 2017;22(1):1–8. DOI: 10.3746/pnf.2017.22.1.1

169. Lowe N.M., Hall A.G., Broadley M.R. et al. Preventing and controlling zinc deficiency across the life course: a call to action. Adv Nutr 2024;15(3):100181. DOI: 10.1016/j.advnut.2024.100181

170. Wessels I., Fischer H.J., Rink L. Dietary and physiological effects of zinc on the immune system. Annu Rev Nutr 2021;41:133–75. DOI: 10.1146/annurev‑nutr‑122019‑120635

171. Zečević N., Veselinović A., Perović M., Stojsavljević A. Association between zinc levels and the impact of its deficiency on idiopathic male infertility: an up‑to‑date review. Antioxidants (Basel) 2025;14(2):165. DOI: 10.3390/antiox14020165

172. Нашивочникова Н.А., Крупин В.Н., Крупин А.В., Леанович В.Е. Роль антиоксидантов в комплексном лечении больных хроническим простатитом. Урология 2024;6:76–83. DOI: 10.18565/urology.2024.6.76‑83